Seres Therapeutics, Inc. (MCRB): 10-Q filed Aug 5, 2026

Form type

10-Q

Filing date

Aug 5, 2026

Accession number

0001193125-26-334174

Filer

Seres Therapeutics, Inc. (CIK 1609809)